Similar articles

• Physicochemical separation of A beta subtype from A alpha type erythrogenic toxin produced by T1 strain Streptococcus pyogenes.

  Kamezawa Y, Nakahara T, Nakano S, Abe Y. Kamezawa Y, et al. Adv Exp Med Biol. 1997;418:567-70. doi: 10.1007/978-1-4899-1825-3_131. Adv Exp Med Biol. 1997. PMID: 9331715 No abstract available.
• Purification and characterization of erythrogenic toxins. II. Communication: in vivo biological activities of erythrogenic toxin produced by streptococcus pyogenes strain ny-5.

  Hríbalová V, Knöll H, Gerlach D, Köhler W. Hríbalová V, et al. Zentralbl Bakteriol A. 1980;248(3):314-22. Zentralbl Bakteriol A. 1980. PMID: 7013358
• A new exocellular mitogen from NY5 strain Streptococcus pyogenes antigenically different from erythrogenic toxins A, B, and C.

  Kamezawa Y, Nakahara T, Nakano S, Abe Y. Kamezawa Y, et al. Adv Exp Med Biol. 1997;418:571-6. doi: 10.1007/978-1-4899-1825-3_132. Adv Exp Med Biol. 1997. PMID: 9331716 No abstract available.
• [Purification and properties of non-specific streptococcal extracellular mitogens].

  Alouf JE, Damais C. Alouf JE, et al. Ann Immunol (Paris). 1977 Jan-Mar;128(1-2):37-9. Ann Immunol (Paris). 1977. PMID: 322587 French.
• Purification and characterization of streptococcal proliferative factor.

  Rasmussen EO, Wuepper KD. Rasmussen EO, et al. J Invest Dermatol. 1981 Aug;77(2):246-9. doi: 10.1111/1523-1747.ep12480148. J Invest Dermatol. 1981. PMID: 6168708